Evidence map›Paper›PMID 41470237›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Proteomic Insights into the Retinal Response to PRGF in a Mouse Model of Age-Related Macular Degeneration.

Eduardo Anitua, Francisco Muruzabal, Sergio Recalde, María de la Fuente, Iraia Reparaz, Mikel Azkargorta, Félix Elortza, Mohammad Hamdan Alkhraisat

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eduardo AnituaRegenerative Medicine Laboratory, BTI-Biotechnology Institute, 01007 Vitoria, Spain.ORCID 0000-0002-8386-5303
Francisco MuruzabalRegenerative Medicine Laboratory, BTI-Biotechnology Institute, 01007 Vitoria, Spain.ORCID 0000-0001-7359-1698
Sergio RecaldeRetinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clínica Universitaria de Navarra, 31008 Pamplona, Spain.ORCID 0000-0002-9328-9725
María de la FuenteRegenerative Medicine Laboratory, BTI-Biotechnology Institute, 01007 Vitoria, Spain.ORCID 0000-0002-6820-1517
Iraia ReparazRegenerative Medicine Laboratory, BTI-Biotechnology Institute, 01007 Vitoria, Spain.ORCID 0009-0001-8940-0953
Mikel AzkargortaProteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.ORCID 0000-0001-9115-3202
Félix ElortzaProteomics Platform, Center for Cooperative Research in Biosciences (CIC bioGUNE), Basque Research and Technology Alliance (BRTA), 48160 Derio, Spain.ORCID 0000-0001-8839-5438
Mohammad Hamdan AlkhraisatRegenerative Medicine Laboratory, BTI-Biotechnology Institute, 01007 Vitoria, Spain.ORCID 0000-0003-4422-4527

Funding

Basque Government ZL-2021/00557
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Intercellular Signaling Peptides and ProteinsMacular DegenerationProteomicsRetinaAnimalsDisease Models, AnimalGeographic AtrophyIodatesMiceMice, Inbred C57BLOxidative StressSignal TransductionIntercellular Signaling Peptides and ProteinsIodatessodium iodateage-related macular degeneration (AMD)animal modelgeographic atrophy (GA)plasma rich in growth factors (PRGF)platelet rich plasma (PRP)retinaretinal pigment epithelial cell

Identifiers

PMID41470237
PMCPMC12735198

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.